Watch Ticker

Phathom Pharmaceuticals, Inc. Common Stock

Go to Phathom Pharmaceuticals, Inc. Common Stock Website

$8.70

0.32 (3.79%)
Live
Previous Close

$8.68

Day Range

$8.025 - $8.72

Previous Day Range

$8.33 - $8.71

Market Cap

$585.0 million USD

Day Vol.

1.8 million

Previous Day Vol.

536670

Currency

USD

Primary Exchange

Nasdaq

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule...

Community
  • 0 posts discussing
0

Watchers

0

Visitors

Recent News

Phathom Pharmaceuticals will host a live webcast on August 7, 2025, at 8:00 am EDT to report its Q2 2025 financial results and provide a business update, focusing on their gastrointestinal disease treatments.

Related tickers: PHAT.

Read Full Article

Phathom Pharmaceuticals, a biopharmaceutical company, announced the appointment of Ted Schroeder, a seasoned biopharma leader, to its Board of Directors. Schroeder's deep operational and commercial expertise is expected to be an important asset as Phathom continues to unlock the full potential of its lead product, VOQUEZNA.

Related tickers: PHAT.

Read Full Article
Trending Tickers

Please sign in to view